1. Home
  2. RLAY vs CNL Comparison

RLAY vs CNL Comparison

Compare RLAY & CNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • CNL
  • Stock Information
  • Founded
  • RLAY 2015
  • CNL 2018
  • Country
  • RLAY United States
  • CNL Canada
  • Employees
  • RLAY N/A
  • CNL N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • CNL
  • Sector
  • RLAY Health Care
  • CNL
  • Exchange
  • RLAY Nasdaq
  • CNL NYSE
  • Market Cap
  • RLAY 576.1M
  • CNL 859.5M
  • IPO Year
  • RLAY 2020
  • CNL N/A
  • Fundamental
  • Price
  • RLAY $3.63
  • CNL $10.21
  • Analyst Decision
  • RLAY Strong Buy
  • CNL Strong Buy
  • Analyst Count
  • RLAY 11
  • CNL 1
  • Target Price
  • RLAY $18.40
  • CNL $8.00
  • AVG Volume (30 Days)
  • RLAY 1.5M
  • CNL 63.3K
  • Earning Date
  • RLAY 08-05-2025
  • CNL 01-01-0001
  • Dividend Yield
  • RLAY N/A
  • CNL N/A
  • EPS Growth
  • RLAY N/A
  • CNL N/A
  • EPS
  • RLAY N/A
  • CNL N/A
  • Revenue
  • RLAY $7,679,000.00
  • CNL N/A
  • Revenue This Year
  • RLAY $17.59
  • CNL N/A
  • Revenue Next Year
  • RLAY N/A
  • CNL N/A
  • P/E Ratio
  • RLAY N/A
  • CNL N/A
  • Revenue Growth
  • RLAY N/A
  • CNL N/A
  • 52 Week Low
  • RLAY $1.78
  • CNL $2.43
  • 52 Week High
  • RLAY $10.72
  • CNL $12.04
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 57.25
  • CNL N/A
  • Support Level
  • RLAY $3.50
  • CNL N/A
  • Resistance Level
  • RLAY $3.86
  • CNL N/A
  • Average True Range (ATR)
  • RLAY 0.18
  • CNL 0.00
  • MACD
  • RLAY 0.02
  • CNL 0.00
  • Stochastic Oscillator
  • RLAY 65.79
  • CNL 0.00

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About CNL COLLECTIVE MINING LTD

Collective Mining Ltd is an exploration and development company focused on identifying and exploring prospective mineral projects in South America. The company currently has interest in two projects located in Colombia, namely, Guayabales and San Antonio. The company is responsible for discovering, permitting, and constructing the gold mine in Colombia. The company is rapidly advancing exploration on large-scale copper-gold-molybdenum porphyry targets in the mining-friendly department of Caldas in Colombia. Drilling is underway at the Guayabales project which is strategically located contiguous to the Marmato deposit, with initial assay results ongoing.

Share on Social Networks: